Rapid Phospholipid Turnover after Surfactant Nebulization in Severe COVID-19 Infection: A Randomized Clinical Trial

Am J Respir Crit Care Med. 2022 Feb 15;205(4):471-473. doi: 10.1164/rccm.202110-2279LE.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Administration, Inhalation
  • Biomarkers / metabolism
  • COVID-19 / metabolism
  • COVID-19 / physiopathology
  • COVID-19 Drug Treatment*
  • Humans
  • Nebulizers and Vaporizers
  • Phospholipids / administration & dosage
  • Phospholipids / metabolism*
  • Phospholipids / pharmacokinetics
  • Phospholipids / therapeutic use
  • Pilot Projects
  • Pulmonary Surfactants / administration & dosage*
  • Pulmonary Surfactants / metabolism
  • Pulmonary Surfactants / pharmacokinetics
  • Pulmonary Surfactants / therapeutic use
  • Respiratory Distress Syndrome / drug therapy*
  • Respiratory Distress Syndrome / metabolism
  • Respiratory Distress Syndrome / virology
  • Treatment Outcome

Substances

  • Biomarkers
  • Phospholipids
  • Pulmonary Surfactants
  • SF-RI 1, bovine surfactant preparation